Health News Releases

August 22, 16:30

VFMCRP announces U.S. Court upholds validity of Velphoro® patent

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the U.S. District Court for the District of Delaware issued a judgment in VFMCRP’s favor regarding U.S. patent no. 9,561,251 whi

August 19, 14:50

Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Produ

August 18, 16:40

Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a rituxim

August 10, 11:10

Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic

Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) will hold a meeting on September 22

August 05, 11:10

GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution

Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a nov

August 04, 17:25

ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial

ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that it is now ready to initiate a phase 1 clinical trial in the United States. Immu

August 04, 15:45

First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half of 2022, as it expanded its research pipeline in a

August 04, 14:40

SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination f

August 03, 11:55

Adalvo Acquires Its First Branded Product, Onsolis®

The global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty pharmaceutical Company, that

August 03, 11:05

Wilhelm von Haller is Chief Financial Officer of Lysando AG

Lysando AG - market leader in the field of antimicrobial proteins - is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an exp

August 02, 17:05

Finalization of Vifor Pharma acquisition

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition

August 02, 11:30

Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.

Graminex®, L.L.C. is pleased to announce it has completed a clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study wa

July 29, 14:00

Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance

Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2022 (period ended June 30, 2022) and is on track to meet its full-year management guidance.

July 29, 11:20

Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate

Organon (NYSE: OGN), a global women’s healthcare company, and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigatio

July 28, 11:10

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a significant expansion of its world-class facility in Tredegar, Wales, UK, desi

July 26, 15:00

EssilorLuxottica Modernizes Order Processing With Boomi’s Intelligent Integration Platform

Boomi™, the intelligent connectivity and automation leader, today announced that EssilorLuxottica, a global leader in the eyewear market, has implemented Boomi's integration platform as a service (iPa

July 25, 16:23

Increased Adoption of Imaging Technology To Detect And Monitor Ailment Severity Is Accelerating The Mobile Imaging Services Industry In Asia Pacific: Scrutinized Report By Fact.MR

The mobile imaging services market is predicted to account for USD 2.7 billion in 2032, up from USD 1.9 billion in 2022, advancing at a CAGR of 3.9% during the forecast period (2022-2032). The incr

July 22, 16:10

Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Takeda (TSE:4502/NYSE:TAK) today announced that ADVANCE-1, a randomized, placebo-controlled, double-blind Phase 3 clinical trial evaluating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombina

July 22, 13:45

Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma

Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for the treatment of peripheral nerve injuries (PNI),

July 22, 09:55

Siemens Korea Digital Industries Holds 9th Smart NC Contest Award Ceremony

Digital Industries (DI) of Siemens Korea (Siemens Ltd. Seoul·SLS) held the 9th Smart Numerical Control (NC) Contest Award Ceremony on July 21 at the Korea Digital Enterprise Experience Center (KDEXc)

July 22, 09:40

DentalMonitoring: July Product Announcements

DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with

July 21, 16:20

Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs

February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies u

July 21, 14:30

Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery

Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s an

July 21, 09:40

STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project

REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation exper

July 20, 14:00

Prestigous West Coast Academic Medical Center Renews Six-Figure, Multi-Year Agreement For Privacy And Security Managed Services

CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issue

News by Region

News by Industry